These mediators exacerbate SSc by phosphorylating mTOR and its downstream effector molecules S6K and S6, indicating that activation of the mTOR pathway plays a crucial role in the initiation of inflammatory cascade manifested in cutaneous SSc [159]. The gene discussed is MTOR; the disease is systemic sclerosis.